Integrated BioPharma, Inc. (INBP)

Integrated BioPharma Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	1.32	0.33	0.21	0.4	0.48
Short-Term Investments	0	0.01	0.07	0.13	0.08
Cash & Cash Equivalents	1.32	0.33	0.21	0.4	0.48
Cash Growth	297.58%	57.62%	-47.76%	-15.37%	108.33%
Receivables	4.51	4.89	5.78	5.51	4.44
Inventory	10.26	11.06	11.7	10.1	8.82
Other Current Assets	0.28	0.34	0.25	0.32	0.26
Total Current Assets	16.37	16.63	18	16.46	14.08
Property, Plant & Equipment	4.28	3.78	4.11	4.52	5.06
Other Long-Term Assets	4.78	4.85	3.34	1.96	0.65
Total Long-Term Assets	9.06	8.62	7.44	6.48	5.71
Total Assets	25.43	25.25	25.44	22.94	19.79
Accounts Payable	2.27	3.21	3.5	4.36	3.86
Deferred Revenue	-2.27	0	0	0	0
Current Debt	0.93	0.64	4.13	7.36	7.35
Other Current Liabilities	3.9	1.41	1.61	1.38	1.15
Total Current Liabilities	4.83	5.26	9.24	13.1	12.35
Long-Term Debt	1.74	1.41	1.87	3.78	5.54
Total Long-Term Liabilities	1.74	1.41	1.87	3.78	5.54
Total Liabilities	6.57	6.68	11.11	16.88	17.9
Total Debt	2.67	2.06	6	11.14	12.9
Debt Growth	30.02%	-65.75%	-46.12%	-13.65%	-11.44%
Common Stock	0.06	0.06	0.06	0.06	0.06
Retained Earnings	-32.34	-32.31	-36.14	-44.16	-48.26
Comprehensive Income	0	0	0	0	0
Shareholders' Equity	18.86	18.58	14.33	6.07	1.89
Total Liabilities and Equity	25.43	25.25	25.44	22.94	19.79
Net Cash / Debt	-1.36	-1.71	-5.72	-10.6	-12.34
Net Cash Per Share	-0.05	-0.05	-0.18	-0.34	-0.42
Working Capital	11.54	11.36	8.76	3.36	1.73
Book Value Per Share	0.63	0.62	0.48	0.21	0.07

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.